ALLOGENEIC BONE MARROW TRANSPLANTATION

Clinical trials for ALLOGENEIC BONE MARROW TRANSPLANTATION explained in plain language.

Never miss a new study

Get alerted when new ALLOGENEIC BONE MARROW TRANSPLANTATION trials appear

Sign up with your email to follow new studies for ALLOGENEIC BONE MARROW TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope to tame dangerous transplant complication

Disease control Recruiting now

This trial is testing a drug called ruxolitinib as the first treatment for acute graft-versus-host disease (GVHD), a serious complication where donor cells attack the body after a bone marrow transplant. It will compare ruxolitinib alone to standard steroid treatment for lower-ri…

Matched conditions: ALLOGENEIC BONE MARROW TRANSPLANTATION

Phase: PHASE2 • Sponsor: John Levine • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

ALLOGENEIC BONE MARROW TRANSPLANTATION

Get alerted when new ALLOGENEIC BONE MARROW TRANSPLANTATION trials appear

New hope to tame dangerous transplant complication